Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep376 | Diabetes (pathiophysiology & epitemiology) | ECE2015

Gonadal hormone regulates the expression MATE1 and OCT2 in type 2 diabetes mice

Ai Ligen , Zhang Dandan , Hou Wolin , Lu Junxi , Tang Junling , Lu Huijuan , Zheng Taishan , Liu Fang

Background and aims: Multi-drug and toxin extrusion 1 (MATE1) and organic cation transporters 2 (OCT2) are important proteins of metformin transport and excretion in liver and kidney. Our previous study showed that there were gender difference of metformin’s hypoglycaemic effect and it was independently linked with the oestrogen and testosterone levels in type 2 diabetes patients. This study was designed to observe the impact of oestrogen and androgen on the renal express...

ea0035p579 | Endocrine tumours and neoplasia | ECE2014

Efficacy and safety of lanreotide Autogel treatment for carcinoid syndrome in patients with gastroenteropancreatic neuroendocrine tumors: results of ELECT, a large multinational phase 3 study

Gomez-Panzani Edda , Vinik Aaron , Wolin Edward , Audry Helen

Introduction: Somatostatin analogues (SSAs) are the mainstay treatment for carcinoid syndrome. ELECT is a large multinational phase 3 study evaluating rescue therapy use as a measure for control of carcinoid syndrome symptoms with LAN-ATG.Methods: Eligible patients had histologically-confirmed GEP-NETs and history of carcinoid syndrome, and were SSA-naïve or responsive to conventional doses of octreotide LAR (≤30 mg/4 weeks) or short-acting (&...

ea0043oc31 | Meta-Analysis of Phase 2/3 Studies | WCTD2016

Do mobile phone applications improve glycemic control in the self-management of diabetes: A systematic review, meta-analysis and GRADE of 14 RCTs

Carter Ben , Hou Can , Hewitt Jonathon , Francisa Trevor , Mayor Sharon

Background: Diabetes mobile phone applications (hereafter referred to as diabetes apps) are a promising tool for self-management. Due to the ubiquitous, low cost, interactive and dynamic health promotion, and there is potential for a cost-effective intervention in diabetes self-care. However, there is uncertainty of the clinical effectiveness.Objectives: To investigate the effect of mobile phone applications on glycemic control in the self -management of...

ea0070oc4.4 | Pituitary and Neuroendocrinology | ECE2020

Thyrotropin/Thyrotropin receptor signaling deficiency impairs spatial learning and memory

Luan Sisi , Hou Xu , He Zhao , Zhao Jiajun

Purpose: Subclinical hyperthyroidism is associated with cognitive impairment, but the mechanism has remained unclear. As subclinical hyperthyroidism is characterized by significantly decreased thyrotropin (TSH) levels, this study aimed to investigate whether TSH regulates cognitive function.Methods: The correlation between TSH and cognitive impairment was investigated in a cross-sectional population study including 382 participants wi...

ea0005oc12 | Cardiovascular Endocrinology | BES2003

Corticosteroid effects at the trafficking level on the pathway of key importance in blood pressure control

Hou J , Seckl J , Chapman K , Brown R

Regulation of the epithelial sodium channel (ENaC) trafficking in cells of the distal nephron is of major importance in the control of sodium reabsorption. Mutations in the genes compromising the molecular pathway by which corticosteroids regulate ENaC sodium reabsorption cause several hypertensive syndromes in humans. The molecular events underpinning ENaC exo- and endocytosis and the hormonal effects on ENaC trafficking are poorly understood. To start elucidating these pathw...

ea0089c1 | Clinical – Chemo/SSA/Biologics | NANETS2022

Progression-Free Survival in Patients with Bronchopulmonary Neuroendocrine Tumors Treated with Lanreotide or Placebo: Adjustment for Crossover Effects in Placebo Arm

Singh Simron , Buikhuisen Wieneke , Capdevila Jaume , Caplin Martyn E , Grohe Christian , Horsch Dieter , Raderer Markus , Reidy-Lagunes Diane , Wolin Edward M , Pommie Christelle , Mai Truong Xuan , Baudin Eric

Background: SPINET was a phase 3 trial (NCT02683941) in patients with well-differentiated, advanced bronchopulmonary neuroendocrine tumors (NETs; typical and atypical carcinoids [TCs and ACs]). During the double-blind (DB) period, patients were randomized (2:1) to receive lanreotide autogel/depot (LAN; 120 mg) or placebo (PBO) every 28 days; in the optional open-label (OL) phase, all patients received LAN. Recruitment was stopped early due to slow accrual; all eligible patient...

ea0047oc8 | Spotlight on Neuroendocrine tumours | Theranostics2016

NETTER-1 Phase III in Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-Dotatate: Efficacy, Safety, QoL Results and Subgroup Analysis

Strosberg Jonathan , Wolin E , Chasen B , Kulke M , Bushnell D , Caplin M , Baum R P , Kunz P , Hobday T , Hendifar A , Oberg K , Lopera Sierra M , Kwekkeboom D , Ruszniewski P , Krenning E

Background: Currently, there are limited therapeutic options for patients with advanced midgut neuroendocrine tumors progressing on first-line somatostatin analog therapy.Methods: NETTER-1 is the first phase III, randomized trial evaluating 177Lu-DOTA0-Tyr3-Octreotate (Lutathera®) in patients with progressive, somatostatin receptor positive midgut NETs. 230 patients were randomized to receive Lutathera 7.4...

ea0081ep85 | Adrenal and Cardiovascular Endocrinology | ECE2022

Assessment of glucolipid metabolism in patients with Cushing’s syndrome caused by adrenal adenoma

Li Jie , Zhang Jiaxin , Yang Guimei , Hou Xintong , Yang Dan , Yang Jing , Zhang Yi , Liu Yunfeng

Backgrounds: Based on anthropometry and blood biochemical tests, this study aims to analyze the variation of glucose and lipid metabolism in Cushing’s syndrome (CS) patients caused by adrenal adenoma combining with flash glucose monitoring system (FGMS) and dual-energy X-ray absorptiometry (DEXA).Methods: According to the strict diagnostic and exclusion criteria, seven healthy controls (HCs) and seven CS patients were collected in this study. First,...

ea0089b15 | Basic Science | NANETS2022

Targeting the TCA Cycle with Histone Deacetylase and Nicotinamide Phosphoribosyltransferase Inhibitors Uncovers a Critical Role for YAP1 in Neuroendocrine Cells

Scotto PhD Luigi , Safari PhD Maryam , Hou Ping , Fojo, MD PhD Tito , Bates MD Susan

Background: More than 12,000 people in the United States are diagnosed with a NET each year and approximately 175,000 people are living with this diagnosis. Little progress has been made in the therapy of NETs over the last two decades, and identification of new vulnerabilities remains a priority.Methods: We used two libraries of compounds selected for potential repurposing and identified agents with the highest cytotoxic activity in neuroendocrine model...

ea0073aep60 | Adrenal and Cardiovascular Endocrinology | ECE2021

Assessment of glucolipid metabolism in patients with nonfunctional adrenal incidentaloma

Li Jie , Zhang Jiaxin , Yang Guimei , Hou Xintong , Yang Dan , Yang Jing , Zhang Yi , Liu Yunfeng

BackgroundsThe study aimed to explore the characteristics of glucolipid metabolism in patients with nonfunctional adrenal incidentaloma(NFAI). And investigate the relationship between these factors and insulin resistance, islet beta cell function.MethodsThis study enrolled eight patients with nonfunctional adrenal incidentaloma and five healthy controls(HCs). These data were recorded including body measuremen...